Clinical Study - Ref20C15
A pilot study on the liver protective effect of silybinphosphatidylcholine complex(Siliphos®) in chronic active hepatitis
G. Buzzelli, S1., Moscarella, A. 1, Giusti, A. 1, Duchini, C. 1, Marena and M.Lampertico 2,1
1.Instituto di Clinica Medica , Universita Degli Studi di Firenze, Firenze and2. Medical Department, Inverni Dell Beffa, Milan Italy
Int. J. Clin. Pharmacol. Ther. Toxicol. 31, 456 (1993)
This was a 20 patient study. 10 patients were treated and 10 were given a placebo. Liver enzyme levels were reduced by 20-30% on average with just one week of usage.Inconclusion, IdB 1016 (Siliphos®) seems to improve the biochemical signs ofhepatocellular necrosis and/or increases cellular permeability in patients affectedby chronic active hepatitis.
This chart shows the dramatic decrease in elevated liver enzymes in patients with chronic active hepatitis after just 7 days of using the active ingredient in Maximum Milk Thistle® daily.